University of the Sciences Launches Cannabis MBA Program
University of the Sciences announced a new program for students interested in the cannabis industry: a specialized Cannabis Industry Masters of Business Administration (MBA) option.
University of the Sciences (USciences, Philadelphia, Pennsylvania) announced a new program for students interested in the cannabis industry: a specialized Cannabis Industry Masters of Business Administration (MBA) option (1). Enrollment is currently open with online courses set to begin in September.
According the University, the coursework is an option of USciences’ specialized MBA in pharmaceutical and healthcare business, which is a hybrid curriculum with students taking courses online with occasional visits to campus. The “Cannabis Industry Option” MBA is reportedly the first of its kind in the U.S., offering education in the business of cannabis, hemp, and dispensary operations. The cannabis option was created in partnership with USciences’ Substance Use Disorders Institute as well as feedback from individuals in the industry. The option includes four elective courses specific to medical cannabis regulations and industry such as “Introduction to the Medical Cannabis Industry;” “Finance and Regulation in the Medical Cannabis Industry;” and “Cannabis Marketing and Sales.” There is also a project-based course where students will work to write a business plan or bring a product to market.
Andrew Peterson, executive director of the Substance Use Disorders Institute, who was integral in the creation of the courses explained that there are many unique aspects to the medical cannabis and hemp industries. “This new program will help to formalize those teachings for those currently in the cannabis industry, entering the field, or interested in other fields associated with the industry,” said Peterson.
“As the industry grows, and the potential for medical cannabis to converge with the pharmaceutical industry, a specialization in pharmaceutical and healthcare business will be an asset to those in the cannabis industry,” said Peterson. “A combination of healthcare, pharmaceutical, and cannabis business knowledge and expertise will be incredibly valuable as graduates move forward in their career.”
For more information about this new program visit usciences.edu/CannabisMBA (2).
References:
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
